Las Vegas Sands' stock gained 4.78%, or $2.67 a share, to $58.55 in morning trading after S&P Dow Jones said it will replace Nektar Therapeutics (NKTR) - Get Report in the S&P 500. Las Vegas Sands' move to the S&P 500 will take place prior to the start of trading on Oct. 3.
Las Vegas Sands is also the parent of Macau licensee Sands China Ltd., and is also pursuing a casino license in Japan.
Save 57% During Our Fall Sale. Join Jim Cramer's Action Alerts PLUS investment club to become a smarter investor. Click here to sign up and save!